Len Liptak, CEO of ProSomnus, and Bill Chen, CEO & Chairman of Lakeshore Acquisition I Corp.

This week, we speak with Len Liptak, CEO of ProSomnus Sleep
Technologies, which announced a $168 million combination with
Lakeshore Acquisition I Corp. (Nasdaq: LAAA), in May.


ProSomnus has developed a new device to treat obstructive sleep
apnea that disrupts the need for its millions of sufferers to be
connected to ventilators at night. Len explains how the COVID-19
pandemic increased the need for sleep apnea treatments, and how
this deal will help power its continued commercialization.


Lakeshore I CEO and Chairman Bill Chen joins to tell us why it
was important that ProSomnus is already generating revenue and
how SPACs can still compete for quality targets in the current
market.